tiprankstipranks
Trending News
More News >
Shanghai Henlius Biotech, Inc. Class H (HK:2696)
:2696
Hong Kong Market

Shanghai Henlius Biotech, Inc. Class H (2696) Revenue

Compare
1 Followers

Shanghai Henlius Biotech, Inc. Class H Revenue

Shanghai Henlius Biotech, Inc. Class H had a revenue of 1.37B in the quarter ending Jun 30, 2024, with 0.00%. This bring the company's revenue in the last twelve months to 5.64B, Decreased 2.23%. In the fiscal year ending Dec 31, 2023, Shanghai Henlius Biotech, Inc. Class H had annual revenue of 5.39B with 67.82% growth.
Revenue (ttm)
5.64B
Revenue Growth
4.23%
P/S Ratio
3.81
Revenue/Employee
HK$1,534,825
Employees
3,515
Market Cap
HK$20.57B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 20235.39B2.18B+67.82%
Dec 31, 20223.21B1.53B+91.07%
Dec 31, 20211.68B1.09B+186.34%
Dec 31, 2020587.59M496.66M+546.20%
Dec 31, 201990.93M83.51M+1,125.29%
Dec 31, 20187.42M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis